Encyclopedia of stem cells – Identification of regulatory networks in hematopoietic stem cells and their immediate progeny
In this study, scientists from the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) present integrated quantitative proteome, transcriptome and DNA-methylome analyses of hematopoietic stem cells (HSCs) and four multipotent progenitor (MPP) populations. The groups headed by Andreas Trumpp, Christoph Plass, Michael Milsom (DKFZ), Jeroen Krijgsveld and Wolfgang Huber (EMBL) participated in this study. By characterization of more than 6,000 proteins, 27,000 transcripts and 15,000 differentially methylated regions (DMRs) they identified coordinated changes associated with early differentiation steps. DMRs show continuous gain or loss of DNA methylation during differentiation, and the overall change in DNA methylation inversely correlates with gene expression at key loci. The data reveal the differential expression landscape of 493 transcription factors and 682 lncRNAs and highlight specific expression clusters operating in HSCs. The authors also found an unexpectedly dynamic pattern of transcript isoform regulation, suggesting a critical regulatory role during HSC differentiation, and a cell cycle/DNA repair signature associated with multipotency in MPP2 cells. This study provides a comprehensive genome-wide resource for functional exploration of molecular, cellular and epigenetic regulation at the top of the hematopoietic hierarchy.
Nina Cabezas-Wallscheid, Daniel Klimmeck, Jenny Hansson, Daniel B. Lipka, Alejandro Reyes, Qi Wang, Dieter Weichenhan, Amelie Lier, Lisa von Paleske, Simon Renders, Peer Wünsche, Petra Zeisberger, David Brocks, Lei Gu, Carl Herrmann, Simon Haas, Marieke A. G. Essers, Benedikt Brors, Roland Eils, Wolfgang Huber, Michael D. Milson, Christoph Plass, Jeroen Krijgsveld, and Andreas Trumpp: Identification of Regulatory Networks in HSCs and their Immediate Progeny Via Integrated Proteome, Transcriptome and DNA Methylome Analysis. Cell Stem Cell 2014, 10.1016/j.stem.2014.07.005
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.